Evidence map›Paper›PMID 30976025›Full record

ArticleScientific reports2019

Accurate target identification for Mycobacterium tuberculosis endoribonuclease toxins requires expression in their native host.

Melvilí Cintrón, Ju-Mei Zeng, Valdir C Barth, Jonathan W Cruz, Robert N Husson, Nancy A Woychik

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Type II Toxin-Antitoxin Systems inInfection and drug resistance · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Are all VapC toxins ofJournal of biosciences · 2024
    Article
  12. Identification of Genes Encoded Toxin-Antitoxin System inInfectious disorders drug targets · 2024
    Article
  13. The life and times of a tRNA.RNA (New York, N.Y.) · 2023
    Review
  14. Article
  15. Article
  16. Antibiotics (Basel, Switzerland) · 2023
    Article
  17. Review
  18. tRNAAntimicrobial agents and chemotherapy · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Melvilí CintrónDepartment of Biochemistry and Molecular Biology, Rutgers University, Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.
Ju-Mei ZengDivision of Infectious Diseases, Boston Children's Hospital/Harvard Medical School, Boston, MA, 02115, USA.
Valdir C BarthDepartment of Biochemistry and Molecular Biology, Rutgers University, Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.ORCID http://orcid.org/0000-0002-7410-1598
Jonathan W CruzDepartment of Biochemistry and Molecular Biology, Rutgers University, Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA.
Robert N HussonDivision of Infectious Diseases, Boston Children's Hospital/Harvard Medical School, Boston, MA, 02115, USA.
Nancy A WoychikDepartment of Biochemistry and Molecular Biology, Rutgers University, Robert Wood Johnson Medical School, Piscataway, NJ, 08854, USA. nancy.woychik@rutgers.edu.
Rutgers, The State University of New Jersey · USBoston Children's Hospital · US

Funding

UMDNJ-RUTGERS UNIVERSITY PIPELINE PROGRAMR25GM055145 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI HAIMOVICH, BEATRICE, LANGER, JEROME ALAN · 1996 to 2020
$8.7M
Membrane Protein Production Using the Yeast SPP SystemR01GM095693 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI WOYCHIK, NANCY ANN · 2010 to 2013
$1.3M
Genome-scale tracking of Mycobacterium tuberculosis VapC toxinsR21AI135461 · NIAID · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI WOYCHIK, NANCY ANN · 2018 to 2019
$470k
Functional analysis of Mycobacterium tuberculosis VapC toxinsF31GM111057 · NIGMS · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI CINTRON, MELVILI · 2014 to 2016
$97k
NIAID NIH HHS R21 AI135461NIGMS NIH HHS F31 GM111057NIGMS NIH HHS R01 GM095693NIGMS NIH HHS R25 GM055145
6 · The paper itself

Abstract

The Mycobacterium tuberculosis genome harbors an unusually high number of toxin-antitoxin (TA) systems. These TA systems have been implicated in establishing the nonreplicating persistent state of this pathogen during latent tuberculosis infection. More than half of the M. tuberculosis TA systems belong to the VapBC (virulence associated protein) family. In this work, we first identified the RNA targets for the M. tuberculosis VapC-mt11 (VapC11, Rv1561) toxin in vitro to learn more about the general function of this family of toxins. Recombinant VapC-mt11 cleaved 15 of the 45 M. tuberculosis tRNAs at a single site within their anticodon stem loop (ASL) to generate tRNA halves. Cleavage was dependent on the presence of a GG consensus sequence immediately before the cut site and a structurally intact ASL. However, in striking contrast to the broad enzyme activity exhibited in vitro, we used a specialized RNA-seq method to demonstrate that tRNA cleavage was highly specific in vivo. Expression of VapC-mt11 in M. tuberculosis resulted in cleavage of only two tRNA isoacceptors containing the GG consensus sequence, tRNA

Indexed as

Toxin-Antitoxin SystemsBacterial ProteinsBacterial ToxinsEndoribonucleasesGene Expression Regulation, BacterialHumansMycobacterium tuberculosisTuberculosisVirulenceBacterial ProteinsBacterial ToxinsEndoribonucleases

Identifiers

PMID30976025
PMCPMC6459853
OpenAlexW2940338145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.